ナカムラ シンイチ   NAKAMURA Shinichi
  中村 真一
   所属   医学部 医学科(東京女子医科大学病院)
   職種   教授
論文種別 原著
言語種別 英語
査読の有無 査読なし
表題 The skill qualification system for portal hypertension in Japan.
掲載誌名 正式名:DEN open
略  称:DEN Open
ISSNコード:26924609/26924609
掲載区分国内
巻・号・頁 2(1),pp.e74
著者・共著者 OHTA Masayuki, MURASHIMA Naoya, OHYAMA Tetsuji, YOSHIDA Tomoharu, HIROTA Shozo, KAWANAKA Hirofumi, HASHIZOME Makoto, NAKAMURA Shinichi, CHIKAMORI Fumio, EGUCHI Susumu, TAJIRI Takashi, OBARA Katsutoshi, KOKUBU Shigehiro
発行年月 2022/04
概要 OBJECTIVES:The diverse treatments available for portal hypertension require specialized knowledge of hemodynamics and include endoscopic treatments, interventional radiology (IVR), and surgery. The Japan Society for Portal Hypertension has developed the skill qualification system (SQS) for portal hypertension and began examination in 2014. Here, the status and validity of the judgment of the SQS examination were evaluated.METHODS:From 2014 to 2020, 79 applicants were evaluated by the SQS for portal hypertension. Each unedited video submitted as a candidate procedure was evaluated by two judges, and a grade of greater than 70% for the scoring items assessed by the judges was required to pass the examination. Inter-rater agreement of success/failure between the two judges was investigated by the AC1 coefficient.RESULTS:The results of two judges differed for 11 of the 79 videos (13.9%), and five applicants (6.3%) ultimately failed the examination. The percentages of total points received by the applicants with endoscopic treatments, IVR, and surgery were 87.3%, 79.4%, and 80.8%, respectively. There were significant differences in the percentages between endoscopic treatments and IVR (P = 0.0015). The AC1 coefficients were 0.84 for the applicants overall, 0.93 for endoscopic treatments, 0.66 for IVR, and 0.72 for surgery. Similarly, there were significant differences in the AC1 coefficient between endoscopic treatments and IVR (P = 0.021).CONCLUSIONS:The SQS for portal hypertension of the Japan Society for Portal Hypertension showed high reliability for video assessments by the judges. This system may contribute to the spread and further development of safe and effective treatments for portal hypertension in Japan.
DOI 10.1002/deo2.74
PMID 35310701